alexa Targets of Antifungal Therapy.
e-ISSN: 2347-7857 p-ISSN: 2347-7849

Research & Reviews: Journal of Pharmaceutics and Nanotechnology
Open Access

Like us on: https://twitter.com/PharmaNanotech
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication

Targets of Antifungal Therapy.

Bharathisha BS1*, Prasanna Sagar2, SB Puranik3, Swamy Sreenivasa4, and Madhu Chakrapani Rao5

1Research Scholar, Bundelkhand University, Jhansi, Madhya Pradesh, India.

2Gland Pharma Pvt Ltd, Hyderabad, Andhra Pradesh, India.

3East West College of Pharmacy, Bangalore, Karnataka, India.

4Prof. C. N. Rao Center for Advanced Materials, Department of Chemistry, Tumkur University, Tumkur-572 103, Karnataka, India.

5Tadimety Aromatics Pvt. Ltd, Hirehally Industrial Area, Tumkur-572168, Karnataka, India.

*Corresponding Author:
Bharathisha BS
Bundelkhand University, Jhansi, Madhya Pradesh, India.

Received date: 10/01/2014 Revised date: 20/02/2014 Accepted date: 28/02/2014

 

Abstract

The recent trend or expansion of antifungal drug research has demonstrated that there is a critical need for new antifungal agents to treat these life-threatening invasive infections. Invasive fungal infections are the critical in treating immunocompromised patients. The overview of the development of antifungal therapy discussed in this article reflects the increased interest in this area of infectious diseases. Although newer, less toxic, antifungal agents are available for clinical use, their clinical efficacy in some invasive fungal infections, such as aspergillosis and fusariosis, is not optimal. Thus, intense efforts in antifungal drug discovery are still needed to develop more promising and effective antifungal agents for use in the clinical arena.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords